Right sided colon cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The clinical stage of patients with colon adenocarcinoma was stage II-III; 2. Patients with tumors located in ileocecal region, ascending colon and hepatic flexure colon; 3. Patients who have not received anti-tumor treatment before operation, including chemotherapy, radiotherapy, radiotherapy and chemotherapy; 4. Male and female patients, aged 18-75 years old; 5. Subjects with ECoG physical status of 0-2 points; 6. Patients with expected survival time > 6 months; patients who can cooperate to observe adverse reactions and curative effects.
Exclusion criteria
Exclusion criteria: 1. For the subjects with AST and / or ALT > 2.5 * ULN, serum total bilirubin > 1.5 * ULN; 2. The absolute count of neutrophil (ANC) was less than 1.5 * 10 ^ 9 / L, or platelet was less than 75 * 10 ^ 9 / L, or Hb was less than 90g / L; 3. Subjects with Cr > 1.5 * ULN; 4. Subjects with the second primary malignant tumor in the past five years, except for skin basal cell carcinoma or cervical carcinoma in situ after adequate treatment; 5. Subjects with any of the following diseases within 12 months before enrollment: myocardial infarction, severe / unstable angina pectoris, coronary / peripheral artery bypass grafting, symptomatic congestive heart failure or cerebrovascular accident; 6. Subjects with positive serum HIV antibody; 7. Subjects currently participating in other clinical trials; 8. Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lymph node metastasis rate of right gastroomentum vessel; | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of right gastric omentum vascular lymph nodes; | — |
Countries
China
Contacts
Sun Yat-Sen University Cancer Center